Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Researchers discover how cancer cells can trigger chronic muscle wasting condition

Researchers discover how cancer cells can trigger chronic muscle wasting condition

Texas leads in worksite lactation support initiatives, research shows

Texas leads in worksite lactation support initiatives, research shows

Label-free laser microscopy technique accurately detects ovarian metastatic cancer

Label-free laser microscopy technique accurately detects ovarian metastatic cancer

PSA testing can help detect prostate cancer in men with BRCA2 gene fault

PSA testing can help detect prostate cancer in men with BRCA2 gene fault

Genetic testing may help patients with metastatic breast cancer

Genetic testing may help patients with metastatic breast cancer

Study shows safety, efficacy of fertility-sparing surgery for treatment of early-stage ovarian cancer

Study shows safety, efficacy of fertility-sparing surgery for treatment of early-stage ovarian cancer

Study links FAK protein to chemotherapy resistance in ovarian cancer

Study links FAK protein to chemotherapy resistance in ovarian cancer

New test could enable early detection of ovarian cancer

New test could enable early detection of ovarian cancer

New therapy found to be effective for patients with a particular type of bone marrow cancer

New therapy found to be effective for patients with a particular type of bone marrow cancer

Cancer survivors could be at greater risk of cardiovascular diseases

Cancer survivors could be at greater risk of cardiovascular diseases

New Recommendation Statement for BRCA1/2 evaluation still fails to address many problems

New Recommendation Statement for BRCA1/2 evaluation still fails to address many problems

Protein governing platinum-resistant ovarian cancer identified

Protein governing platinum-resistant ovarian cancer identified

Targeted pancreatic cancer drug shows promise in clinical trials

Targeted pancreatic cancer drug shows promise in clinical trials

New drug to treat pancreatic cancer shows promising results in clinical trial

New drug to treat pancreatic cancer shows promising results in clinical trial

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park receives more than $15 million in grants for cancer research

Management of ovarian cancer risk in women with BRCA1/2 gene mutations

Management of ovarian cancer risk in women with BRCA1/2 gene mutations

Researchers identify gene mutation combo linked to endometrial cancer

Researchers identify gene mutation combo linked to endometrial cancer

New device traps and analyzes single cells for faster HPV-related cervical cancer screening

New device traps and analyzes single cells for faster HPV-related cervical cancer screening

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

Research links inherited BRCA2 mutations with increased risk of childhood lymphoma

Women who inherit BRCA mutations have high risk of developing cancer

Women who inherit BRCA mutations have high risk of developing cancer